ATE503687T1 - Verfahren zur herstellung von formulierungen für inhaliergeräte mit abgemessener dosis - Google Patents

Verfahren zur herstellung von formulierungen für inhaliergeräte mit abgemessener dosis

Info

Publication number: ATE503687T1
Authority: AT; Austria
Prior art keywords: dose inhaler; metered dose; container; suspension; solution
Prior art date: 2002-08-27

Application number

AT07119781T

Other languages

English (en)

Inventor

Saeed Chaudhry

Stefan Sharpe

Julianne Berry

Joel Sequeira

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-27

Filing date

2003-08-26

Publication date

2011-04-15

2003-08-26 Application filed by Schering Corp filed Critical Schering Corp

2011-04-15 Application granted granted Critical

2011-04-15 Publication of ATE503687T1 publication Critical patent/ATE503687T1/de

Links

238000000034 method Methods 0.000 title abstract 3
239000000203 mixture Substances 0.000 title 1
229940071648 metered dose inhaler Drugs 0.000 abstract 6
239000000725 suspension Substances 0.000 abstract 4
229960002744 mometasone furoate Drugs 0.000 abstract 2
WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
239000003380 propellant Substances 0.000 abstract 1
238000007789 sealing Methods 0.000 abstract 1
239000004094 surface-active agent Substances 0.000 abstract 1

Classifications

- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
- B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
- B65B31/003—Adding propellants in fluid form to aerosol containers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Mechanical Engineering (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Dispersion Chemistry (AREA)
Biophysics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

AT07119781T 2002-08-27 2003-08-26 Verfahren zur herstellung von formulierungen für inhaliergeräte mit abgemessener dosis ATE503687T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US40612702P	2002-08-27	2002-08-27
US42243602P	2002-10-30	2002-10-30

Publications (1)

Publication Number	Publication Date
ATE503687T1 true ATE503687T1 (de)	2011-04-15

Family

ID=31981380

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT07119781T ATE503687T1 (de)	2002-08-27	2003-08-26	Verfahren zur herstellung von formulierungen für inhaliergeräte mit abgemessener dosis
AT03791745T ATE384001T1 (de)	2002-08-27	2003-08-26	Verfahren zur herstellung von dosierinhalatorformulierungen

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT03791745T ATE384001T1 (de)	2002-08-27	2003-08-26	Verfahren zur herstellung von dosierinhalatorformulierungen

Country Status (14)

Country	Link
US (3)	US20040042973A1 (de)
EP (2)	EP1542904B1 (de)
JP (3)	JP4679901B2 (de)
AT (2)	ATE503687T1 (de)
AU (1)	AU2003265639A1 (de)
CA (1)	CA2495875C (de)
CY (1)	CY1107376T1 (de)
DE (2)	DE60336602D1 (de)
DK (1)	DK1542904T3 (de)
ES (1)	ES2297262T3 (de)
MX (1)	MXPA05002248A (de)
PT (1)	PT1542904E (de)
SI (1)	SI1542904T1 (de)
WO (1)	WO2004020289A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0207906D0 (en)	2002-04-05	2002-05-15	3M Innovative Properties Co	Formoterol and mometasone aerosol formulations
CA2495689A1 (en) *	2002-08-23	2004-03-04	Schering Corporation	Pharmaceutical compositions
CA2542530A1 (en) *	2003-10-20	2005-05-12	Schering Corporation	Pharmaceutical aerosol compositions
SE0401408D0 (sv) *	2004-06-02	2004-06-02	Astrazeneca Ab	Diameter measuring device
EP1811981B1 (de) *	2004-10-12	2008-08-13	Merck Generics (UK) Limited	Verfahren zur herstellung von suspensionsaerosolformulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden
US20070099883A1 (en) *	2005-10-07	2007-05-03	Cheryl Lynn Calis	Anhydrous mometasone furoate formulation
US20090325917A1 (en) *	2006-10-19	2009-12-31	Cipla Limited	Pharmaceutical Compositions and Nasal Spray Incorporating Anhydrous Mometasone Furoate
US20080253970A1 (en) *	2007-02-09	2008-10-16	Schering Corporation	Stable Pharmaceutical Drug Products
EP2117504A1 (de)	2007-02-09	2009-11-18	Schering Corporation	Stabile pharmazeutische wirkstoff-aerosole
WO2010130428A1 (en)	2009-05-12	2010-11-18	Galenica Ab	Oil-in-water emulsion of mometasone and propylene glycol
SMT201700066T1 (it) *	2009-05-12	2017-05-08	Galenica Ab	Emulsione olio-in-acqua di mometasone
AU2015200276B2 (en) *	2010-02-10	2016-01-21	Astrazeneca Uk Limited	A filled canister for an inhaler
WO2011098798A1 (en) *	2010-02-10	2011-08-18	Astrazeneca Uk Limited	Process for providing a filled canister for an inhaler
CN107626019A (zh) *	2016-07-18	2018-01-26	卓效医疗有限公司	手持式喷雾器
CN107951893B (zh) *	2016-10-18	2022-04-26	天津金耀集团有限公司	一种糠酸莫米松粉吸入剂组合物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3592319A (en) *	1968-10-28	1971-07-13	Roy S Rousseau	Article feed control
US3835898A (en) *	1972-11-13	1974-09-17	Kartridg Pak Co	Remotely adjustable filling head
US4793461A (en) *	1987-02-26	1988-12-27	The Kartridg Pak Co.	Container feed apparatus
US5143260A (en) *	1990-06-05	1992-09-01	Nozone Dispenser Systems, Inc.	Aerosol adapter clamp and power system
US5182097A (en) *	1991-02-14	1993-01-26	Virginia Commonwealth University	Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
DK1277467T3 (da) *	1991-06-10	2007-01-15	Schering Corp	Formuleringer af ikke-chlorfluorcarbonaerosoler
ES2200771T3 (es) *	1991-06-10	2004-03-16	Schering Corporation	Formulaciones en aerosol no clorofluorocarbonadas.
US5275212A (en) *	1993-02-24	1994-01-04	Minnesota Mining And Manufacturing Company	Aerosol filling method
GB9612297D0 (en)	1996-06-11	1996-08-14	Minnesota Mining & Mfg	Medicinal aerosol formulations
US5698161A (en)	1996-08-26	1997-12-16	Michigan Critical Care Consultants, Inc.	Hollow, multi-dimensional array membrane
US6068832A (en) *	1996-08-29	2000-05-30	Schering Corporation	Chlorofluorocarbon-free mometasone furoate aerosol formulations
EP0927037B1 (de) *	1996-08-29	2001-07-11	Schering Corporation	Chlorfluorkohlenwasserstoff freie aerosol-arzneizubereitungen enthaltend mometasonfuroat
US20060165606A1 (en) *	1997-09-29	2006-07-27	Nektar Therapeutics	Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6004537A (en) *	1998-12-18	1999-12-21	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9904919D0 (en) *	1999-03-03	1999-04-28	Novartis Ag	Organic compounds
EP1248597B1 (de) *	1999-12-24	2005-03-30	Glaxo Group Limited	Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
AU2001278115A1 (en) *	2000-08-04	2002-02-18	Longwood Pharmaceutical Research, Inc.	Formulations of mometasone and a bronchodilator for pulmonary administration
ITMI20010428A1 (it) *	2001-03-02	2002-09-02	Chemo Breath S A	Composizioni ad uso inalatorio a base di formoterolo
TWI324934B (en) *	2001-08-28	2010-05-21	Schering Corp	Pharmaceutical compositions for the treatment of asthma
GB0207906D0 (en) *	2002-04-05	2002-05-15	3M Innovative Properties Co	Formoterol and mometasone aerosol formulations
CA2495689A1 (en) *	2002-08-23	2004-03-04	Schering Corporation	Pharmaceutical compositions
CA2542530A1 (en) *	2003-10-20	2005-05-12	Schering Corporation	Pharmaceutical aerosol compositions
EP1981545A2 (de) *	2006-02-09	2008-10-22	Schering Corporation	Pharmazeutische formulierungen
US20080253970A1 (en) *	2007-02-09	2008-10-16	Schering Corporation	Stable Pharmaceutical Drug Products

2003
- 2003-08-26 WO PCT/US2003/026512 patent/WO2004020289A1/en not_active Ceased
- 2003-08-26 PT PT03791745T patent/PT1542904E/pt unknown
- 2003-08-26 EP EP03791745A patent/EP1542904B1/de not_active Expired - Lifetime
- 2003-08-26 AT AT07119781T patent/ATE503687T1/de not_active IP Right Cessation
- 2003-08-26 EP EP07119781A patent/EP1878664B1/de not_active Expired - Lifetime
- 2003-08-26 AT AT03791745T patent/ATE384001T1/de active
- 2003-08-26 ES ES03791745T patent/ES2297262T3/es not_active Expired - Lifetime
- 2003-08-26 CA CA2495875A patent/CA2495875C/en not_active Expired - Fee Related
- 2003-08-26 DK DK03791745T patent/DK1542904T3/da active
- 2003-08-26 SI SI200331133T patent/SI1542904T1/sl unknown
- 2003-08-26 JP JP2004532972A patent/JP4679901B2/ja not_active Expired - Fee Related
- 2003-08-26 AU AU2003265639A patent/AU2003265639A1/en not_active Abandoned
- 2003-08-26 DE DE60336602T patent/DE60336602D1/de not_active Expired - Lifetime
- 2003-08-26 DE DE60318727T patent/DE60318727T2/de not_active Expired - Lifetime
- 2003-08-26 MX MXPA05002248A patent/MXPA05002248A/es active IP Right Grant
- 2003-08-27 US US10/649,398 patent/US20040042973A1/en not_active Abandoned
2006
- 2006-08-18 JP JP2006223635A patent/JP2006305390A/ja active Pending
2007
- 2007-11-30 US US11/948,688 patent/US20080066744A1/en not_active Abandoned
2008
- 2008-03-31 CY CY20081100362T patent/CY1107376T1/el unknown
2010
- 2010-10-08 JP JP2010229135A patent/JP2011046726A/ja not_active Withdrawn
2012
- 2012-08-23 US US13/592,899 patent/US20130068218A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DK1542904T3 (da)	2008-04-21
US20040042973A1 (en)	2004-03-04
DE60318727T2 (de)	2009-01-08
US20080066744A1 (en)	2008-03-20
DE60336602D1 (de)	2011-05-12
SI1542904T1 (sl)	2008-06-30
JP2011046726A (ja)	2011-03-10
WO2004020289A1 (en)	2004-03-11
US20130068218A1 (en)	2013-03-21
JP2006305390A (ja)	2006-11-09
ES2297262T3 (es)	2008-05-01
EP1878664A1 (de)	2008-01-16
EP1878664B1 (de)	2011-03-30
JP2005537095A (ja)	2005-12-08
CY1107376T1 (el)	2012-12-19
MXPA05002248A (es)	2005-06-08
CA2495875A1 (en)	2004-03-11
CA2495875C (en)	2010-06-22
AU2003265639A1 (en)	2004-03-19
EP1542904B1 (de)	2008-01-16
PT1542904E (pt)	2008-03-24
ATE384001T1 (de)	2008-02-15
DE60318727D1 (de)	2008-03-06
JP4679901B2 (ja)	2011-05-11
EP1542904A1 (de)	2005-06-22

Legal Events

Date	Code	Title	Description
2011-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
CY1107376T1 (el)	2012-12-19	Μεθοδος παρασκευης συνταγοποιησεων για συσκευη εισπνοης μετρημενης δοσης
Amarnath et al.	2014	Biomaterials for dental implants: an overview
FI2515855T6 (fi)	2023-06-02	Yhdistelmähoito keuhkoahtaumatautia (copd) varten
FI109875B (fi)	2002-10-31	Painekaasupakkauksia, jotka on saatu käyttämällä polyoksietyleeniglyseryylioleaatteja
CA2353959A1 (en)	2000-06-15	A medicinal aerosol formulation
EA200100338A1 (ru)	2001-10-22	Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента
Canoglu et al.	2012	Effect of bleaching agents on sealing properties of different intraorifice barriers and root filling materials
MX2014004364A (es)	2014-05-27	Composiciones que comprenden sulfato de salbutamol.
MX2014004279A (es)	2014-05-28	Composiciones que comprenden sulfato de salbutamol.
GB201118188D0 (en)	2011-12-07	Manufacture of medicinal aerosol canisters
RU2016141961A (ru)	2018-04-28	Несмываемая химическая пена, содержащая пероксид бензоила
TW200630116A (en)	2006-09-01	Post-foaming dental mousse and methods utilizing the same
Brauer et al.	1972	Bonding of bovine enamel to restorative resin: effect of pretreatment of enamel
JPH07502954A (ja)	1995-03-30	エアゾールバルブ
ATE293957T1 (de)	2005-05-15	Verfahren zur herstellung von inhalationspulvern
WO2002024261A3 (en)	2002-08-01	Shock wave aerosolization apparatus and method
US20160220465A1 (en)	2016-08-04	Minoxidil formulations
CA2404426C (en)	2011-07-19	Foamable dental fluoride composition
CN110547977B (zh)	2022-07-15	一种含小苏打的口腔护理组合物及其制备方法和应用
KR20170030583A (ko)	2017-03-17	이산화 탄소 외용제 조제용 조성물, 그 제조 방법, 이산화 탄소 외용제, 및 화장용 팩
JP6018438B2 (ja)	2016-11-02	滴下式エアゾール製品
CN109526949A (zh)	2019-03-29	一种安全环保的气雾剂的制备方法、气雾剂
CN103751814A (zh)	2014-04-30	制备长有效期的锝[99mTc]亚甲基二膦酸盐注射液药品的方法
JP6152368B2 (ja)	2017-06-21	二酸化炭素外用剤調製用組成物、その製造方法及び化粧用パック
RU142097U1 (ru)	2014-06-20	Ингалятор